Bin‐Bing S. Zhou

7.2k total citations · 2 hit papers
42 papers, 5.6k citations indexed

About

Bin‐Bing S. Zhou is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Bin‐Bing S. Zhou has authored 42 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 20 papers in Oncology and 14 papers in Cell Biology. Recurrent topics in Bin‐Bing S. Zhou's work include DNA Repair Mechanisms (16 papers), Cancer-related Molecular Pathways (12 papers) and Microtubule and mitosis dynamics (10 papers). Bin‐Bing S. Zhou is often cited by papers focused on DNA Repair Mechanisms (16 papers), Cancer-related Molecular Pathways (12 papers) and Microtubule and mitosis dynamics (10 papers). Bin‐Bing S. Zhou collaborates with scholars based in United States, China and Australia. Bin‐Bing S. Zhou's co-authors include Stephen J. Elledge, Jiří Bártek, Kenneth G. Geles, Peter B. Dirks, Haiying Zhang, Marc Damelin, Justin C. Grindley, Kum Kum Khanna, Michael R. Mattern and Priya Chaturvedi and has published in prestigious journals such as Nature, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Bin‐Bing S. Zhou

41 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The DNA damage response: putting checkpoints in perspective

2000 2.6k citations Bin‐Bing S. Zhou, Stephen J. Elledge Nature profile →
Tumour-initiating cells: challenges and opportunities for anticancer drug discovery

2009 687 citations Bin‐Bing S. Zhou et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bin‐Bing S. Zhou United States	19	4.5k	2.4k	1.1k	1.0k	391	42	5.6k
Randi G. Syljuåsen Norway	26	4.7k 1.0×	2.5k 1.1×	1.4k 1.3×	950 0.9×	340 0.9×	55	5.3k
Eva Petermann United Kingdom	33	5.5k 1.2×	2.7k 1.1×	838 0.8×	982 1.0×	475 1.2×	47	6.2k
Mark Rolfe United States	31	4.6k 1.0×	2.5k 1.0×	1.2k 1.1×	570 0.6×	321 0.8×	55	6.0k
Chris J. Norbury United Kingdom	40	5.5k 1.2×	1.7k 0.7×	1.4k 1.3×	1.1k 1.0×	417 1.1×	68	7.1k
Alwin Krämer Germany	39	4.0k 0.9×	2.2k 0.9×	1.8k 1.6×	814 0.8×	522 1.3×	124	5.9k
Michael H.G. Kubbutat Germany	31	4.6k 1.0×	3.6k 1.5×	707 0.6×	904 0.9×	284 0.7×	73	6.5k
Shuhei Matsuoka Japan	12	6.6k 1.5×	3.1k 1.3×	1.3k 1.2×	1.4k 1.4×	695 1.8×	14	7.3k
Christine E. Canman United States	34	6.0k 1.3×	4.1k 1.7×	910 0.8×	1.6k 1.6×	368 0.9×	49	7.2k
Christopher J. Bakkenist United States	34	5.5k 1.2×	2.6k 1.1×	656 0.6×	1.5k 1.4×	392 1.0×	82	6.6k
Jacob Falck Denmark	26	6.2k 1.4×	3.2k 1.3×	1.4k 1.3×	1.6k 1.6×	634 1.6×	28	6.9k

Countries citing papers authored by Bin‐Bing S. Zhou

Since Specialization

Citations

This map shows the geographic impact of Bin‐Bing S. Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin‐Bing S. Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin‐Bing S. Zhou more than expected).

Fields of papers citing papers by Bin‐Bing S. Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bin‐Bing S. Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin‐Bing S. Zhou. The network helps show where Bin‐Bing S. Zhou may publish in the future.

Co-authorship network of co-authors of Bin‐Bing S. Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Bin‐Bing S. Zhou. A scholar is included among the top collaborators of Bin‐Bing S. Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bin‐Bing S. Zhou. Bin‐Bing S. Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ding, Ming, Yanyan Lin, Yao Chen, et al.. (2025). Therapeutic targeting de novo purine biosynthesis driven by β-catenin-dependent PPAT upregulation in hepatoblastoma. Cell Death and Disease. 16(1). 179–179. 3 indexed citations

Yao, Chen, Huiying Sun, Xiaoyu Wu, et al.. (2024). Up-regulation of ABCG1 is associated with methotrexate resistance in acute lymphoblastic leukemia cells. Frontiers in Pharmacology. 14. 1331687–1331687. 5 indexed citations

Tang, Chao, Huiying Sun, Xiaomeng Li, et al.. (2023). Targeting DNA polymerase β elicits synthetic lethality with mismatch repair deficiency in acute lymphoblastic leukemia. Leukemia. 37(6). 1204–1215. 8 indexed citations

Xu, Yan, Yao Chen, Ya‐Bin Tang, et al.. (2022). The KRAS-G12D mutation induces metabolic vulnerability in B-cell acute lymphoblastic leukemia. iScience. 25(3). 103881–103881. 5 indexed citations

Chen, Yao, Yan Xu, Ming Ding, et al.. (2022). A γ‐glutamyl hydrolase lacking the signal peptide confers susceptibility to folates/antifolates in acute lymphoblastic leukemia cells. FEBS Letters. 596(4). 437–448. 8 indexed citations

Dong, Xiao, Lili Mu, Si‐Cong Yang, et al.. (2020). Biomimetic, Hypoxia‐Responsive Nanoparticles Overcome Residual Chemoresistant Leukemic Cells with Co‐Targeting of Therapy‐Induced Bone Marrow Niches. Advanced Functional Materials. 30(12). 43 indexed citations

Wang, Dan, Yao Chen, Liang Zheng, et al.. (2018). Increase of PRPP enhances chemosensitivity of PRPS1 mutant acute lymphoblastic leukemia cells to 5‐Fluorouracil. Journal of Cellular and Molecular Medicine. 22(12). 6202–6212. 12 indexed citations

Wang, Xinkang, Yutian Zhan, Lei Zhao, et al.. (2011). Multimodal Biomarker Investigation on Efficacy and Mechanism of Action for the Mammalian Target of Rapamycin Inhibitor, Temsirolimus, in a Preclinical Mammary Carcinoma OncoMouse Model: A Translational Medicine Study in Support for Early Clinical Development. Journal of Pharmacology and Experimental Therapeutics. 339(2). 421–429. 9 indexed citations

DiJoseph, John F., Maureen Dougher, Deborah Y. Evans, Bin‐Bing S. Zhou, & Nitin K. Damle. (2010). Preclinical anti-tumor activity of antibody-targeted chemotherapy with CMC-544 (inotuzumab ozogamicin), a CD22-specific immunoconjugate of calicheamicin, compared with non-targeted combination chemotherapy with CVP or CHOP. Cancer Chemotherapy and Pharmacology. 67(4). 741–749. 37 indexed citations

10.

Fabbro, Megan, Bin‐Bing S. Zhou, Mikiko Takahashi, et al.. (2005). Cdk1/Erk2- and Plk1-Dependent Phosphorylation of a Centrosome Protein, Cep55, Is Required for Its Recruitment to Midbody and Cytokinesis. Developmental Cell. 9(4). 477–488. 262 indexed citations

11.

Zhou, Bin‐Bing S. & Jiří Bártek. (2004). Targeting the checkpoint kinases: chemosensitization versus chemoprotection. Nature reviews. Cancer. 4(3). 216–225. 322 indexed citations

12.

Krause, Darren, Magtouf Gatei, Herman H.W. Silljé, et al.. (2003). Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1. Oncogene. 22(38). 5927–5937. 73 indexed citations

13.

Chen, Ping, Lakshmanan K. Iyer, Chang Hun Lee, et al.. (2002). Determination of Substrate Motifs for Human Chk1 and hCds1/Chk2 by the Oriented Peptide Library Approach. Journal of Biological Chemistry. 277(18). 16102–16115. 124 indexed citations

14.

Zhao, Baoguang, Michael J. Bower, Patrick McDevitt, et al.. (2002). Structural Basis for Chk1 Inhibition by UCN-01. Journal of Biological Chemistry. 277(48). 46609–46615. 169 indexed citations

15.

Ye, Ruiqiong, et al.. (2001). The Plant Isoflavenoid Genistein Activates p53 and Chk2 in an ATM-dependent Manner. Journal of Biological Chemistry. 276(7). 4828–4833. 79 indexed citations

16.

Gatei, Magtouf, Bin‐Bing S. Zhou, Karen Hobson, et al.. (2001). Ataxia Telangiectasia Mutated (ATM) Kinase and ATM and Rad3 Related Kinase Mediate Phosphorylation of Brca1 at Distinct and Overlapping Sites. Journal of Biological Chemistry. 276(20). 17276–17280. 157 indexed citations

17.

Zhou, Bin‐Bing S. & Stephen J. Elledge. (2000). The DNA damage response: putting checkpoints in perspective. Nature. 408(6811). 433–439. 2572 indexed citations breakdown →

18.

Chaturvedi, Priya, Yuan Zhu, Michael R. Mattern, et al.. (1999). Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene. 18(28). 4047–4054. 345 indexed citations

19.

Zhou, Bin‐Bing S. & Marc W. Kirschner. (1999). Quantitative measurement of the catastrophe rate of dynamic microtubules. Cell Motility and the Cytoskeleton. 43(1). 43–51. 8 indexed citations

20.

Zhou, Bin‐Bing S. & H. K. Schachman. (1993). Peptide‐protein interaction markedly alters the functional properties of the catalytic subunit of aspartate transcarbamoylase. Protein Science. 2(1). 103–112. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact